CT evaluation of coronary artery disease

CT Evaluation of Coronary Artery Disease

Volumn , Issue , 2009, Pages 1-165

  Pavone, Paolo ^a,b   Fioranelli, Massimo ^c   Dowe, David A ^d  

^a MATER DEI HOSPITAL   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c GUGLIELMO MARCONI UNIVERSITY   (Italy)

^d Atlantic Medical Imaging   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892351738     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-88-470-1126-7     Document Type: Book

References (160)

1. Abbate A, Bonanno E, Mauriello A et al (2004) Widespread myocardial inflammation and infarct-related artery patency. Circulation 110(1):46-50
2. Achenbach S (2006) Top 10 indications for coronary CTA. Applied Radiology 35:22-31
3. Airoldi F, Colombo A, Morici N et al (2007) Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment. Circulation 116:745-754
4. Alderman EL, Stadius ML (1992) The angiographic definitions of the Bypass Angioplasty Revascularization Investigation (BARI). Coron Artery Dis 3:1189-1120
5. André P, Nannizzi-Alaimo L, Prasad SK, Phillips DR (2002) Platelet-derived CD40L: the switch-hitting player of cardiovascular disease. Circulation 106(8):896-899
6. Antman EM, Cohen M, Bernink PJ et al (2000) The TIMI risk score for unstable angina/ non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA 284:835-842
7. Arbustini E, Grasso M, Diegoli M et al (1993) Coronary thrombosis in non cardiac death. Coron Artery Dis 4:751-759
8. Ardissino D, Cavallini C, Bramucci E et al (2004) Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: a randomized trial. JAMA 292:2727-2734
9. Ardissino D, Merlini PA, Bauer KA et al (2003) Coagulation activation and long-term outcome in acute coronary syndromes. Blood 102(8):2731-2735
10. Associazione Nazionale Medici Cardiologi Ospedalieri (2000) Trattato di Cardiologia.
11. Excerpta Medica, San Donato Milanese, Milan Austen WG, Edwards JE, Frye RL et al (1975) A reporting system on patients for coronary artery disease: report of the ad hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 51 (Suppl 4):5-40
12. Baim DS, Cutlip DE, Midei M et al (2001) Final results of a randomized trial comparing the MULTI-LINK stent with the Palmaz-Schatz stent for narrowings in native coronary arteries. Am J Cardiol 87:157-162
13. Baim DS, Cutlip DE, O'Shaughnessy CD, et al (2001) Final results of a randomized trial comparing the NIR stent to the Palmaz-Schatz stent for narrowings in native coronary arteries. Am J Cardiol 87:152-156
14. Bayes-Genis A, Conover CA, Overgaard MT et al (2001) Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N Engl J Med 345(14):1022-1029
15. Biasucci LM, Liuzzo G, Ciervo A et al (2003) Antibody response to chlamydial heat shock protein 60 is strongly associated with acute coronary syndromes. Circulation 107(24):3015-3017
16. Biasucci LM, Liuzzo G, Grillo RL et al (1999) Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation 99(7):855-860
17. Braunwald E (1989) Unstable angina. A classification. Circulation 80:410-414
18. Braunwald E (1997) Heart disease: a textbook of cardiovascular medicines. 5th ed. W.B. Saunders Company, Philadelphia Brenner DJ, Hall EJ (2007) Computed tomography. An increasing source of radiation exposure. N Engl J Med 357:2277-2284
19. Briguori C, De Gregorio J, Nishida T et al (2000) Polytetrafluoroethylene-covered stent for the treatment of narrowings in aorticocoronary saphenous vein grafts. Am J Cardiol 86:343-346
20. Briguori C, Sarais C, Pagnotta P et al (2002) In-stent restenosis in small coronary arteries: impact of strut thickness. J Am Coll Cardiol 40:403-409
21. Budoff MJ, Shaw LJ, Liu ST et al (2007) Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. J Am Coll Cardiol 49:1860-1870
22. Budoff MJ, Shinbane JS (2006) Cardiac CT imaging: diagnosis of cardiovascular disease. Springer Berlin Heidelberg New York
23. Buffon A, Biasucci LM, Liuzzo G et al (2002) Widespread coronary inflammation in unstable angina. N Engl J Med 347(1):5-12
24. Cademartiri F, Casolo G, Midiri M (2007) La TC del cuore nella pratica clinica. Springer
25. Milano Cademartiri F, Mollet N, Lemos PA et al (2005) Usefulness of multislice computed tomographic coronary angiography to assess in-stent restenosis. Am J Cardiol 96:799-802
26. CathSAP II, American College of Cardiology, Society for Cardiac Angiography and Interventions. http://www.acc.org/ed ucation/pro ducts/suite-co re.htm Chevalier B (2008) NOBORI 1-long term results: two years phase 1, one year phase 2. Scientific Session, Late Breaking Trials, Euro PCR
27. Barcelona Chevalier B, Serruys PW, Silber S et al (2007) Randomised comparison of Nobori TM, biolimus A9-eluting coronary stent with Taxus, paclitaxel-eluting coronary stent in patients with stenosis in ntive coronary arteries: the Nobori 1 trial. EuroIntervention 2:426-434
28. Chiurlia E, Menozzi M, Ratti C et al (2005) Follow-up of coronary artery bypass graft patency by multislice computed tomography. Am J Cardiol 95:1094-1097
29. Cohen MC, Hartnell GG, Finn JP (1994) Magnetic resonance angiography of congenital pulmonary vein anomalies. Am Heart J 127:954-955
30. Colombo A, Drzewiecki J, Banning A et al (2003) Randomized study to assess the effectiveness of slow-and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 108:788-794
31. Colombo A, Hall P, Nakamura S et al (1995) Intracoronary stenting without anti-coagulation accomplished with intravascular ultrasound guidance. Circulation 91:1676-1688
32. Colombo A, Stankovic G, Moses JW (2002) Selection of coronary stents. J Am Coll Cardiol 40:1021-1033
33. Coronary Artery Disease, ACCSAP-6, American College of Cardiology, http://www.acc.org/education/products/suite-core.htm. Cited in March 2005
34. Daemen J, Wenaweser P, Tsuchida K et al (2007) Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 369:667-678
35. Davies MJ, Thomas A (1984) Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N Engl J Med 310(18):1137-1140
36. De Palma R, Del Galdo F, Abbate G et al (2006) Patients with acute coronary syndrome show oligoclonal T-cell recruitment within unstable plaque: evidence for a local, intracoronary immunologic mechanism. Circulation 113(5):640-646
37. Dewey M, Lembcke A, Enzweiler C et al (2004) Isotropic half-millimeter angiography of coronary artery bypass grafts with 16-slice computed tomography. Ann Thorac Surg 77:800-804
38. Eagle KA, Guyton RA (2004) ACC/AHA 2004 Guideline update for coronary artery by-pass graft surgery. J Am Coll Cardiol
39. Ehara S, Kobayashi Y, Yoshiyama M et al (2004) Spotty calcification typifies the culprit plaque in patients with acute myocardial infarction. An intravascular ultrasound study. Circulation 110:3424-3429
40. Engelmann MG, Knez A, von Smekal A et al (2000) Non-invasive coronary bypass graft imaging after multivessel revascularization. Int J Cardiol 76:65-74
41. Engelmann MG, von Smekal A, Knez A et al (1997) Accuracy of spiral computed tomography for identifying arterial and venous coronary graft patency. Am J Cardiol 80:569-574
42. Erbel R, Di Mario C, Bartunek J et al (2007) Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial. Lancet 369:1869-1875
43. Erhardt L, Herlitz J, Bossaert L et al (2002) Task force on the management of chest pain. Eur Heart J 23:1153-1176
44. Fischman DL, Leon MB, Baim DS et al (1994) A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 331:496-501
45. Gallagher MJ, Raff GL (2008) Use of multislice CT for the evaluation of emergency room patients with chest pain: the so-called "triple rule-out". Catheter Cardiovasc Interv 71:92-99
46. Garasic JM, Edelman ER, Squire JC et al (2000) Stent and artery geometry determine intimal tickening independent of artery injury. Circulation 101:812-818
47. Gershlick A, De Scheerder I, Chevalier B et al (2004) Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent: the European evaLUation of pacli-Taxel Eluting Stent (ELUTES) trial. Circulation 109:487-493
48. Gilard M, Cornily JC, Pennec PY et al (2005) Assessment of coronary artery stents by 16-slice computed tomography. Heart 92:58-61
49. Gilard M, Cornily JC, Rioufol G et al (2005) Noninvasive assessment of left main coronary stent patency with 16-slice computed tomography. Am J Cardiol 95:110-112
50. Goldstein JA, Demetriou D, Grines CL et al (2000) Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med 343(13):915-922
51. Goldstein JA, Gallagher MJ, O'Neill WW et al (2007) A randomized controlled trial of multi-slice coronary computed tomography for evaluation of acute chest pain. J Am Coll Cardiol 49:863-871
52. Grube E, Silber S, Hauptmann KE et al (2004) TAXUS I: six-and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation (2003) 107:38-42
53. Grundy SM, Pasternak R, Greenland P et al (1999) Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations. Circulation 100:1481-1492
54. Guazzi MD, Bussotti M, Grancini L et al (1997) Evidence of multifocal activity of coronary disease in patients with acute myocardial infarction. Circulation 96(4):1145-1151
55. Gurbel PA, Callahan KP, Malinin AI et al (2002) Could stent design affect platelet activation? Results of the Platelet Activation in STenting (PAST) Study. J Invasive Cardiol 14:584-589
56. Han Y (2008) Multicenter Registry of Excel Biodegradable Polymer Drug Eluting Stent (CREATE), 9-months angiographic and 12-months clinical results. American College of Cardiology 2008 Scientific Sessions/i2 Summit-SCAI Annual Meeting) March 31, Chicago, IL. Late-breaking clinical trials 3
57. Hansson GK, Holm J, Jonasson L (1989) Detection of activated T lymphocytes in the human atherosclerotic plaque. Am J Pathol 135:169-175
58. Heeschen C, Dimmeler S, Fichtlscherer S et al. CAPTURE Investigators (2004) Prognostic value of placental growth factor in patients with acute chest pain. JAMA 291(4):435-441
59. Hendel RC, Patel MR, Kramer CM et al (2006) ACCF/ACR/SCCT/SCMR/ASNC/ NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging. J Am Coll Cardiol 48:1475-1497
60. Henneman MM, Schuijf JD, Pundziute G et al (2008) Noninvasive evaluation with multislice computed tomography in suspected acute coronary syndrome: plaque morphology on multislice computed tomography versus coronary calcium score. J Am Coll Cardiol 52:216-222
61. Henschke CI, Yankelevitz DF, Libby DM et al (2006) Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 355:1763-1771
62. Hoffmann U, Millea R, Enzweiler C et al (2004) Acute myocardial infarction: contrast-enhanced multi-detector row CT in a porcine model. Radiology 231:697-701
63. Hoffmann U, Nagurney JT, Moselewski F et al (2006) Coronary multidetector computer tomography in the assessment of patients with acute chest pain. Circulation 114:2251-2260
64. Hong C, Chrysant GS, Woodard PK et al (2004) Coronary artery stent patency assessed with in-stent contrast enhancement measured at multi-detector row CT angiography: initial experience. Radiology 233:286-291
65. Hwang CW, Wu D, Edelman ER (2001) Physiological transport forces govern drug distribution for stent-based delivery. Circulation 104:600-605
66. Iakovou I, Schmidt T, Bonizzoni E et al (2005) Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293:2126-2130
67. Ishikawa T, Hatakeyama K, Imamura T et al (2003) Involvement of C-reactive protein obtained by directional coronary atherectomy in plaque instability and developing restenosis in patients with stable or unstable angina pectoris. Am J Cardiol 91(3):287-292
68. Kaartinen M, Penttila A, Kovanen (1994) Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture. Circulation 90:1669-1678
69. Kalushi E, Tsai S, Klapholz M (2008) Coronary stenting with MGuard: from conception to human trials. Cardiovasc Revasc Med 9(2):88-94
70. Kastrati A, Dirschinger J, Boekstegers P et al (2000) Influence of stent design on 1-year outcome after coronary stent placement: a randomized comparison of five stent types in 1,147 unselected patients. Catheter Cardiovasc Interv 50:290-297
71. Kastrati A, Mehilli J, Dirschinger J et al (2001) Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial. Circulation 103:2816-21
72. Kastrati A, Schomig A, Dirschinger J et al (2000) Increased risk of restenosis after placement of gold-coated stents: results of a randomized trial comparing gold-coated with uncoated steel stents in patients with coronary artery disease. Circulation 101:2478-2483
73. Kim RJ, Fieno DS, Parrish TB et al (1999) Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 100:1992-2002
74. Kirklin JW, Brian G, Barratt-Boyes BG (1993) Cardiac Surgery. Churchill Livingstone
75. Kol A, Sukhova GK, Lichman AH, Libby P (1998) Chlamydial heat shock protein 60. localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression. Circulation 98:300-307
76. Kollum M, Farb A, Schreiber R et al (2005) Particle debris from a nanoporus stent coating obscures potential antiproliferative effects of tacrolimus-eluting stents in a porcine model of restenosis. Catheter Cardiovasc Interv 64(1):85-90
77. Koolen JJ, De Vita MR (2007) LEONARDO-Clinical evaluation of a last generation coronary stent in a real world typical Non-DES population-A prospective, singlecentre registry. Report, Interventional Cardiology, pp 1-3
78. Koyama Y, Mochizuki T, Higaki J (2004) Computed tomography assessment of myocardial perfusion, viability, and function. J Magn Reson Imaging 19:800-815
79. Lansky AJ, Roubin GS, O'Shaughnessy CD et al (2000) Randomized comparison of GR-II stent and Palmaz-Schatz stent for elective treatment of coronary stenoses. Circulation 102:1364-1368
80. Leber AW, Knez A, von Ziegler F et al (2005) Quantification of obstructive and nonobstructive coronary lesions by 64-slice computed tomography. A comparative study with quantitative coronary angiography and intravascular ultrasound. J Am Coll Cardiol 46:147-154
81. Leon MB, Baim DS, Popma JJ et al (1998) A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators. N Engl J Med 339:1665-1671
82. Libby P, Theroux P (2005) Pathophysiology of coronary artery disease. Circulation 111:3481-3488
83. Lin WS, Prakash VS, Tai CT et al (2000) Pulmonary vein morphology in patients with paroxysmal atrial fibrillation initiated by ectopic beats originating from the pulmonary veins: implications for catheter ablation. Circulation 101:1274-1281
84. Liuzzo G, Biasucci LM, Gallimore JR et al (1994) The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 331(7):417-424
85. Liuzzo G, Biasucci LM, Trotta G et al (2007) Unusual CD4+CD28null T lymphocytes and recurrence of acute coronary events. J Am Coll Cardiol 50(15):1450-1458
86. Maintz D, Juergens KU, Wichter T et al (2003) Imaging of coronary artery stents using multislice computed tomography: in vitro evaluation. Eur Radiol 13:830-835
87. Maintz D, Seifarth H, Flohr T et al (2003) Improved coronary artery stent visualization and in-stent stenosis detection using 16-slice computed-tomography and dedicated image reconstruction technique. Invest Radiol 38:790-795
88. Maseri A (2000) Ischemic heart disease. Churchill Livingstone and Saunders, New York
89. Mauri L, Hsieh WH, Massaro JM et al (2007) Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 356:1020-1029
90. McFadden EP, Stabile E, Regar E et al (2004) Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 364:1519-1521
91. Mehran R, Aymong ED, Ashby DT et al (2003) Safety of an aspirin-alone regimen after intracoronary stenting with a heparin-coated stent: final results of the HOPE (HEPACOAT and an Antithrombotic Regimen of Aspirin Alone) study. Circulation 108:1078-1083
92. Miketic S, Carlsson J, Tebbe U (2001) Randomized comparison of J&J Crown stent versus NIR stent after routine coronary angioplasty. Am Heart J 142:E8
93. Min JK (2006) Coronary CTA versus cardiac catheterization: where do we stand today? Applied Radiology 35(12):32-40
94. Moreno PR, Bernardi VH, Lopez-Cuellar J et al (1996) Macrophages, smooth muscle cells, and tissue factor in unstable angina. Implications for cell-mediated thrombogenicity in acute coronary syndromes. Circulation 94(12):3090-3097
95. Morgan-Hughes GJ, Roobottom CA, Marshall AJ (2002) Aortic valve imaging with computed tomography: a review. J Heart Valve Dis 11:604-611
96. Morice MC, Serruys PW, Sousa JE et al (2002) A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346:1773-80
97. Moses JW, Leon MB, Popma JJ et al (2003) Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349:1315-1323
98. Nageh T, de Belder AJ, Thomas MR et al (2001) A randomised trial of endoluminal reconstruction comparing the NIR stent and the Wallstent in angioplasty of long segment coronary disease: results of the RENEWAL Study. Am Heart J 141:971-976
99. Naghavi M, Libby P, Falk E et al (2003) From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation 108:1664-1672
100. Narducci ML, Grasselli A, Biasucci LM et al (2007) High telomerase activity in neutrophils from unstable coronary plaques. J Am Coll Cardiol 50(25):2369-2374
101. Naruko T, Ueda M, Hake K et al (2002) Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation 106:2894-2900
102. Neri Serneri GG, Abbate R, Gori AM et al (1992) Transient intermittent lymphocyte activation is responsible for the instability of angina. Circulation 86(3):790-797
103. Nieman K, Pattynama PM, Rensin BJ et al (2003) Evaluation of patients after coronary artery bypass surgery: CT angiographic assessment of grafts and coronary arteries. Radiology 229:749-756
104. Nikolaou K, Knez A, Sagmeister S et al (2004) Assessment of myocardial infarctions using multirow-detector computed tomography. J Comput Assist Tomogr 28:286-292
105. Nikolaou K, Poon M, Sirol M et al (2003) Complementary results of computed tomography and magnetic resonance imaging of the heart and coronary arteries: a review and future outlook. Cardiol Clin 21:639-655
106. Ong AT, McFadden EP, Regar E et al (2005) Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 45:2088-2092
107. Ormiston JA, Serruys PW, Regar E et al (2008) A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial. Lancet 371:899-907
108. Pache G, Saueressig U, Frydrychowicz A et al (2006) Initial experience with 64-slice cardiac CT: non-invasive visualization of coronary artery bypass grafts. Eur Heart J 27:880-976
109. Pache J, Kastrati A, Mehilli J et al (2003) Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial. J Am Coll Cardiol 41:1283-1288
110. Park SJ, Lee CW, Hong MK et al (2002) Comparison of gold-coated NIR stents with uncoated NIR stents in patients with coronary artery disease. Am J Cardiol 89:872-875
111. Park SJ, Shim WH, Ho DS et al (2003) A paclitaxel-eluting stent for the prevention of coronary restenosis. N Engl J Med 348:1537-1545
112. Perez-Lugones A, Schvartzman PR, Schweikert R et al (2003) Three-dimensional reconstruction of pulmonary veins in patients with atrial fibrillation and controls: morphological characteristics of different veins. Pacing Clin Electrophysiol 26:8-15
113. Perisinakis K, Theocharopoulos N, Karkavitsas N, Damilakis J (2002) Patient effective radiation dose and associated risk from transmission scans using 153Gd line sources in cardiac spect studies. Health Phys 83:66-74
114. Pilleul F, Merchant N (2000) MRI of the pulmonary veins: comparison between 3D MR angiography and T1-weighted spin echo. J Comput Assist Tomogr 24:683-687
115. Pope, JH, Aufderheide TP, Ruthazer R et al (2000) Missed Diagnoses of Acute Cardiac Ischemia in the Emergency Department. N Engl J Med 342:1163-1170
116. Rajtar A, Kaluza GL, Yang Q et al (2006) Hydroxyapatite-coated cardiovascular stents. Euro Intervention, pp 113-115
117. Rastogi A, Stavchansky S (2008) Drug eluting stents and beyond. Curr Pharm Des 14(21):2111-2120
118. Redberg R (2006) Computed tomographic angiography. More than just a pretty picture? J Am Coll Cardiol 49:1827-1829
119. Reifart N, Morice MC, Silber S et al (2004) The NUGGET study: NIR ultra gold-gilded equivalency trial. Catheter Cardiovasc Interv 62:18-25
120. Rioufol G, Finet G, Ginon I et al (2002) Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study. Circulation 106(7):804-808
121. Rogacka R, Chieffo A, Latib A, Colombo A (2008) Bioabsorbable and biocompatible stents. Is a new revolution coming? Minerva Cardioangiol 56:483-491
122. Ropers D, Ulzheimer S, Wenkel E et al (2001) Investigation of aortocoronary artery bypass grafts by multislice spiral computed tomography with electrocardiographicgated image reconstruction. Am J Cardiol 8:792-795
123. Rubinstein R, Halon DA, Gaspar T et al (2007) Usefulness of 64-slice cardiac computed tomographic angiography for diagnosing acute coronary syndromes and predicting clinical outcome in emergency department patients with chest pain of uncertain origin. Circulation 115:1762-1768
124. Sangiorgi GM, Clementi F, Cola C, Biondi-Zoccai G (2007) Plaque vulnerability and related coronary event prediction by intravascular ultrasound with virtual histology: "it's a long way to tipperary"? Catheter Cardiovasc Interv 70:203-210
125. Sangiorgi G, Melzi G, Agostoni P (2007) Engineering aspects of stents design and their translation into clinical practice. Annali dell'Istituto Superiore Sanità 43:89-100
126. Sano T, Tanaka A, Namba M et al (2003) C-reactive protein and lesion morphology in patients with acute myocardial infarction. Circulation 108(3):282-285
127. Schachinger V, Hamm CW, Munzel T et al (2003) A randomized trial of polytetrafluoroethylene-membrane-covered stents compared with conventional stents in aortocoronary saphenous vein grafts. J Am Coll Cardiol 42:1360-1369
128. Schampaert E, Cohen EA, Schluter M et al (2004) The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol 43:1110-1115
129. Schofer J, Schluter M, Gershlick AH et al (2003) Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet 362:1093-1099
130. Schomig A, Neumann FJ, Kastrati A et al (1996) A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 334:1084-1089
131. Schonbeck U, Libby P (2001) CD40 signaling and plaque stability. Circ Res 89:1092-1103
132. Schroeder S, Achenbach S, Bengel F et al (2008) Cardiac computed tomography: indications, applications, limitations, and training requirements: report of a Writing Group deployed by the Working Group Nuclear Cardiology and Cardiac CT of the European Society of Cardiology and the European Council of Nuclear Cardiology. Eur Heart J 29:531-556
133. Schueller G, Schima W, Schueller-Weidekamm C et al (2006) Multidetector CT of pancreas: effects of contrast material flow rate and individualized scan delay on enhancement of pancreas and tumor contrast. Radiology 241:441-448
134. Schuijf JD, Bax JJ, Jukema JW et al (2004) Feasibility of assessment of coronary stent patency using 16-slice computed tomography. Am J Cardiol 94:427-430
135. Schultz RK. REVA Medical Inc (2007) Bioabsorbable stent. scientific session, late breaking trials, CRT, Washington
136. DC Schwartzman D, Lacomis J, Wigginton W (2003) Characterization of left atrium and distal pulmonary vein morphology using multidimensional computed tomography. J Am Coll Cardiol 41:1349-1357
137. Seifarth H, Raupach R, Schaller S et al (2005) Assessment of coronary artery stents using 16-slice MDCT angiography: evaluation of a dedicated reconstruction kernel and a noise reduction filter. Eur Radiol 15:721-726
138. Serruys PW, de Jaegere P, Kiemeneij F et al (1994) A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 331:489-495
139. Sheiban I, Villata G, Bollati M et al (2008) Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V) Vasc Health Risk Manag 4(1):31-38
140. Silber S (2003) Final results of the NIRTOP trial. Euro PCR Symposium, Paris, France
141. Solomon SB, Dickfeld T, Calkins H (2003) Real-time cardiac catheter navigation on three-dimensional CT images. J Interv Card Electrophysiol 8:27-36
142. Spagnoli LG, Bonanno E, Mauriello A et al (2002) Multicentric inflammation in epicardial coronary arteries of patients dying of acute myocardial infarction. J Am Coll Cardiol 40(9):1579-1588
143. Stabile E, Cheneau E, Kinnaird T et al (2004) Late thrombosis in cypher stents after the discontinuation of antiplatelet therapy. Cardiovasc Radiat Med 5:173-176
144. Stoeckel D, Bonsignore C, Duda S (2002) A survey of stent designs. Min Invas Ther & Allied Technol 11:137-147
145. Stone GW, Ellis SG, Cox DA et al (2004) A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350:221-231
146. Tamai H, Igaki K, Kyo E et al (2000) Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans. Circulation 102:399-404
147. Tanajura LF, Abizaid AA, Feres F et al (2003) Randomized intravascular ultrasound comparison between patients that underwent amorphous hydrogenated silicon-carbide coated stent deployment versus uncoated stents (abstr). J Am Coll Cardiol 41:58A
148. Taylor AJ, Burke AP, Tang AL et al (2000) A comparison of the Framingham risk index, coronary artery calcification, and culprit plaque morphology in sudden cardiac death. Circulation 101:1243-1248
149. Thuesen L, Andersen HR, Krusell LR et al (2003) Randomized comparison of the coil-design Crossflex and the tubular NIR stent. Catheter Cardiovasc Interv 59:8-12
150. Tin Hay E, Hou XM, Lim J et al (2007) A novel drug-eluting stent using bioabsorbable polymer technology: Two-year follow-up of the CURAMI registry. Int J Cardiol
151. Unverdorben M, Sippel B, Degenhardt R et al (2003) Comparison of a silicon carbidecoated stent versus a noncoated stent in human beings: the Tenax versus Nir Stent Study's long-term outcome. Am Heart J 145:e17
152. van der Giessen WJ, Lincoff AM, Schwartz RS et al (1996) Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation 94:1690-1697
153. Vanhoenacker PK, Heijenbrok-Kal MH, Van Heste R et al (2007) Diagnostic performance of multidetector CT angiography for assessment of coronary artery disease: meta-analysis. Radiology 244:419-428
154. Virmani R, Kolodgie FD, Burke AP et al (2005) Atherosclerotic. plaque progression and vulnerability to rupture angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 25:2054-2061
155. Willerson JT, Cohn J (2000) Cardiovascular medicine. 2nd ed, Churchill Livingstone and Saunders, New York
156. Windecker S, Simon R, Lins M et al (2005) Randomized comparison of a titanium-nitride-oxide-coated stent with a stainless steel stent for coronary revascularization: the TiNOX trial. Circulation 111:2617-2622
157. Wohrle J, Al-Khayer E, Grotzinger U et al (2001) Comparison of the heparin coated vs the uncoated Jostent-no influence on restenosis or clinical outcome. Eur Heart J 22:1808-1816
158. Wong P, Lau KW, Lim YL, Oesterle SN (2000) Stent placement for non-STRESS/BENESTENT lesions: a critical review. Catheter Cardiovasc Interv 51:223-233
159. Yasojima K, Schwab C, McGeer EG, McGeer PL (2001) Generation of C-reactive protein and complement components in atherosclerotic plaques. Am J Pathol 158(3):1039-1051
160. Yoo KJ, Choi D, Choi BW et al (2003) The comparison of the graft patency after coronary artery bypass grafting using coronary angiography and multi-slice computed tomography. Eur J Cardiothorac Surg 24:86-91